Last updated on April 18, 2014 at 21:21 EDT

Regeneron Announces Upcoming 2013 Investor Conference Presentations

February 19, 2013

TARRYTOWN, N.Y., Feb. 19, 2013 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Citi 2013 Global Healthcare Conference; Dyslipidemia Panel on Tuesday, February 26, 2013. The session is scheduled for 1:30 p.m. Eastern Time.
  • RBC Capital Markets’ 2013 Global Healthcare Conference on Wednesday, February 27, 2013. The presentation is scheduled for 9:30 a.m. Eastern Time.
  • Barclays Global Healthcare Conference on Tuesday, March 12, 2013. The presentation is scheduled for 2:30 p.m. Eastern Time.

The sessions may be accessed through the Company’s web site, www.regeneron.com, on the ‘Events and Presentations’ page. An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, and asthma. For additional information about the company, please visit www.regeneron.com.

    Contact Information:

    Michael Aberman, M.D.         Peter Dworkin
    Investor Relations            Corporate Communications
    914.847.7799                  914.847.7640
    michael.aberman@regeneron.com peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Source: PR Newswire